| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702582 | Urologic Oncology: Seminars and Original Investigations | 2017 | 8 Pages |
Abstract
High Ki-67 expression in localized PCa is a factor of poor prognosis for DSS, biochemical failure-free survival, DFS, DM, and OS after curative-intent treatments. Incorporation into clinical routine of this widely available and standardized biomarker should be strongly considered.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Alejandro M.D., M.Sc., Julio F. M.D., Laura M.D., David M.D., Juan F. M.D., Iván A. M.D., Galileo M.D., Adrian M.D., Francisco E. M.D., M.Sc.,